Home > > Europe And Global Gene Therapy Market- Size, Share, Growth Rate, and Forecast
The Europe Gene Therapy market was valued at $2,445.8 Million in 2023, and is projected to reach $9,805.2 Million by 2030 growing at a CAGR of 22.05% from 2024 to 2030. Non-Viral Vectors segment is expected to be the highest contributor to this market, with $2,057.4 Million in 2023, and is anticipated to reach $6,820.5 by 2030, registering a CAGR of 18.74%. Viral Vectors segment is anticipated to reach $2,984.7 Million by 2030 with the highest CAGR of 33.27%. Vector Non-Viral Vectors Viral Vectors Indication Neurological Diseases Cancer Hepatological Diseases Duchenne Muscular Dystrophy Other Indications Delivery Method In-Vivo Gene Theraoy Ex-Vivo Gene Theraoy BY REGION North America U.s. Canada Europe Germany France U.k. Italy Spain RoE Asia Japan China RoAPAC Middle East & Africa Latin America MEA